Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|December 25, 2010
Immunomodulation and postpartum relapses in patients with multiple sclerosisKerstin Hellwig, Christian Beste, Sebastian Schimrigk, et al.Journal of the Neurological Sciences|May 24, 2011
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosisKerstin Hellwig, Sebastian Schimrigk, Andrew Chan, et al.European Neurology|November 29, 2008
Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosisKerstin Hellwig, Sebastian Schimrigk, Christian Beste, et al.BMC Medical Genetics|May 25, 2002
PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patientsBianca Miterski, Eckhart Sindern, Michael Haupts, et al.Thescientificworldjournal|April 11, 2006
Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosisKerstin Hellwig, Carsten Lukas, Niels Brune, et al.Clinical Neuropharmacology|September 9, 2006
Efficacy of mitoxantrone and intrathecal triamcinolone acetonide treatment in chronic progressive multiple sclerosis patientsKerstin Hellwig, Sebastian Schimrigk, Carsten Lukas, et al.European Neurology|October 27, 2017
Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain PatientsSebastian Schimrigk, Martin Marziniak, Christine Neubauer, et al.Archives of Neurology|May 14, 2008
Allergic and nonallergic delayed infusion reactions during natalizumab therapyKerstin Hellwig, Sebastian Schimrigk, Malte Fischer, et al.Electrophoresis|July 27, 2004
Refining the results of a whole-genome screen based on 4666 microsatellite markers for defining predisposition factors for multiple sclerosisRené Gödde, Viktoria Nigmatova, Peter Jagiello, et al.Therapeutic Advances in Neurological Disorders|December 25, 2010
Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophyCarsten Lukas, Barbara Bellenberg, Horst K Hahn, et al.Pageof 3